Phacilitate Leaders Forum

Europe's leading cell & gene therapy manufacturers in 2016

Europe's leading cell & gene therapy manufacturers in 2016

In the past twelve months, the manufacturing landscape in Europe has been changing as the cell and gene therapy industries move ever closer to commercialization.

To ensure that you have a firm understanding of the current manufacturing outlook within the continent, Phacilitate have been working with leading CMOs to produce an update on the manufacturing infographic we shared 2015 ( available to view here).

To view the updated and more interactive version, please fill in this form below:

Form 'FB_A3FE4B03-5056-B759-7AEEBF7FCD662F15' not found.
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd